thromboxanes has been researched along with Vascular Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunsch, C; Malinin, A; Qiu, FH; Scott, R; Serebruany, V; Xu, XC | 1 |
| Bovill, E; Cornell, E; Feinberg, WM; Hart, RG; Leonard, AD; Pearce, LA; Talbert, RL | 1 |
| Corvera, JS; Guyton, RA; Halkos, ME; Kerendi, F; Kin, H; Mosunjac, M; Vinten-Johansen, J; Zhao, ZQ | 1 |
| McLemore, GR; Ryan, MJ | 1 |
| Oelz, O | 1 |
| Mitchell, JR | 1 |
| Myers, SI; Needleman, P; Zipser, R | 1 |
| McGiff, JC | 2 |
| Folco, G; Maclouf, J; Patrono, C | 1 |
| Maderna, P; Paoletti, R; Tremoli, E | 1 |
| Catella, F; Fitzgerald, DJ; FitzGerald, GA; Lawson, JA | 1 |
| FitzGerald, GA; Murray, JJ; Nowak, J; Oates, JA | 1 |
5 review(s) available for thromboxanes and Vascular Diseases
| Article | Year |
|---|---|
Prostaglandins in vascular disease: a seminal approach.
Topics: Arteriosclerosis; Blood Platelets; Blood Vessels; Diabetes Mellitus; Epoprostenol; Forecasting; Humans; Lipids; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1981 |
Thromboxane and prostacyclin: implications for function and disease of the vasculature.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Diet; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxanes; Vascular Diseases | 1980 |
Eicosanoids and iso-eicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Arachidonic Acid; Cell Differentiation; Cell Division; Cyclooxygenase Inhibitors; Eicosanoids; Enzyme Induction; Humans; Isoenzymes; Membrane Lipids; Membrane Proteins; Microsomes; Nitric Oxide; Oxidation-Reduction; Phospholipids; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Thromboxanes; Vascular Diseases | 1998 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1979 |
Pathological significance of the thromboxane-prostacyclin hypothesis.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Epoprostenol; Humans; Prostaglandins, Synthetic; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vascular Diseases | 1985 |
2 trial(s) available for thromboxanes and Vascular Diseases
| Article | Year |
|---|---|
Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy.
Topics: Adolescent; Adult; Aged; Biomarkers; Cells, Cultured; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Male; Middle Aged; Probucol; Risk Factors; Thromboxanes; Vascular Diseases; Young Adult | 2009 |
Aspirin dosage and thromboxane synthesis in patients with vascular disease.
Topics: Aged; Aspirin; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation Inhibitors; Thromboxane B2; Thromboxanes; Vascular Diseases | 2003 |
7 other study(ies) available for thromboxanes and Vascular Diseases
| Article | Year |
|---|---|
Inhibition of myosin light chain kinase provides prolonged attenuation of radial artery vasospasm.
Topics: Androstadienes; Animals; Apoptosis; Dogs; Endothelial Cells; Free Radical Scavengers; Muscle, Smooth, Vascular; Myosin-Light-Chain Kinase; Norepinephrine; Potassium Chloride; Protein Kinase Inhibitors; Radial Artery; Serotonin; Thromboxanes; Vascular Diseases; Vasoconstriction; Vasoconstrictor Agents; Wortmannin | 2004 |
Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus.
Topics: Acetylcholine; Animals; Antibodies, Antinuclear; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Hypertension; Lupus Erythematosus, Systemic; Mice; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Nitroprusside; Proteinuria; Reverse Transcriptase Polymerase Chain Reaction; RNA; Serotonin; Thromboxanes; Vascular Diseases; Vasodilator Agents | 2007 |
[Clinical significance of prostaglandins and other arachidonic acid metabolites. Prostacyclin (PGI2), thromboxane A2, leukotriene].
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Epoprostenol; Gastrointestinal Diseases; Humans; Kidney Diseases; Lung Diseases; Neoplasms; Prostaglandins; SRS-A; Thromboxane A2; Thromboxanes; Vascular Diseases | 1982 |
Peptide-induced prostaglandin biosynthesis in the renal-vein-constricted kidney.
Topics: Animals; Bradykinin; Constriction; Dinoprostone; In Vitro Techniques; Kidney; Perfusion; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Rabbits; Radioimmunoassay; Renal Veins; Stimulation, Chemical; Thromboxane A2; Thromboxanes; Vascular Diseases | 1981 |
Analysis of multiple thromboxane metabolites in plasma and urine.
Topics: Aspirin; Humans; Thromboxane B2; Thromboxanes; Vascular Diseases | 1987 |
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
Topics: Adult; Blood Platelet Disorders; Blood Platelets; Cotinine; Epoprostenol; Humans; Male; Middle Aged; Nicotine; Platelet Aggregation; Smoking; Thromboxane B2; Thromboxanes; Vascular Diseases | 1987 |
[Prostaglandins and applications in clinical biology].
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Child, Preschool; Chromatography, Gas; Dinoprost; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; Immunoenzyme Techniques; Infant, Newborn; Mass Spectrometry; Prostaglandins; Prostaglandins E; Prostaglandins F; Thromboxane B2; Thromboxanes; Vascular Diseases | 1985 |